The Patent Finder

Bromide Source for Use in Treating Autism Spectral Disorder

Universite de Strasbourg

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 2 of these applications claim priority to application PCT/EP2017/080726, filed Nov 28, 2017. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 12,036,237Bromide Source for Use in Treating Autism Spectral Disorder
In force
 · Medium confidence
UsedRemaining
Inserm, Institut National de la Sante et de la Recherche Medicale, Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Evironnement, CNRS, Centre National de la Recherche Scientifique and Universite de StrasbourgIn forceMedium confidence
US 11,666,599Bromide Source for Use in Treating Autism Spectral Disorder
In force
 · High confidence
Inserm, Institut National de la Sante et de la Recherche Medicale, Inra, Institut National de la Recherche Agronomique, CNRS, Centre National de la Recherche Scientifique and Universite de StrasbourgIn forceHigh confidence
Application 18/733,139Bromide Source for Use in Treating Autism Spectral Disorder
Abandoned
Abandoned Jul 21, 2025
CNRS, Centre National de la Recherche ScientifiqueAbandonedAbandoned Jul 21, 2025
3 of 3 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
2 of these are in force and held by Universite de Strasbourg.
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited